Efficacy and safety of 0.05% cyclosporine ophthalmic emulsion in treatment of Chinese patients with moderate to severe dry eye disease: A 12-week, multicenter, randomized, double-masked, placebo-controlled phase III clinical study

BACKGROUND: Dry eye disease (DED) is a chronic ocular surface disease that affects hundreds of millions of people worldwide. Although 0.05% cyclosporine ophthalmic emulsion (CsA OE) has long been prescribed in the U.S. for the treatment of DED, it is not commercially available in China. Our study ai...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Di, Zhang, Shunhua, Bian, Ailing, Hong, Jing, Deng, Yingping, Zhang, Mingchang, Chen, Wei, Shao, Yan, Zhao, Jialiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6709181/
https://www.ncbi.nlm.nih.gov/pubmed/31374063
http://dx.doi.org/10.1097/MD.0000000000016710

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6709181/
https://www.ncbi.nlm.nih.gov/pubmed/31374063
http://dx.doi.org/10.1097/MD.0000000000016710

Ejemplares similares